DK0501678T3 - Behandling af okulær hypertension med en synergistisk kombination - Google Patents
Behandling af okulær hypertension med en synergistisk kombinationInfo
- Publication number
- DK0501678T3 DK0501678T3 DK92301412.0T DK92301412T DK0501678T3 DK 0501678 T3 DK0501678 T3 DK 0501678T3 DK 92301412 T DK92301412 T DK 92301412T DK 0501678 T3 DK0501678 T3 DK 0501678T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- ocular hypertension
- synergistic combination
- pharmaceutically acceptable
- ketoprostaglandin
- Prior art date
Links
- 206010030043 Ocular hypertension Diseases 0.000 title abstract 3
- 239000011885 synergistic combination Substances 0.000 title abstract 2
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6132891 | 1991-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0501678T3 true DK0501678T3 (da) | 1996-05-28 |
Family
ID=13167964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92301412.0T DK0501678T3 (da) | 1991-03-01 | 1992-02-20 | Behandling af okulær hypertension med en synergistisk kombination |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5547968A (enExample) |
| EP (1) | EP0501678B1 (enExample) |
| JP (1) | JP2511611B2 (enExample) |
| KR (1) | KR100221369B1 (enExample) |
| AT (1) | ATE137407T1 (enExample) |
| CA (1) | CA2061907C (enExample) |
| DE (1) | DE69210286T2 (enExample) |
| DK (1) | DK0501678T3 (enExample) |
| ES (1) | ES2089387T3 (enExample) |
| GR (1) | GR3019820T3 (enExample) |
| TW (1) | TW210287B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001504100A (ja) * | 1996-11-01 | 2001-03-27 | アルコン・ラボラトリーズ・インコーポレーテッド | 緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用 |
| US6214381B1 (en) | 1998-09-08 | 2001-04-10 | Effcon, Inc. | Methazolamide composition and method of use |
| US7128903B2 (en) * | 2001-10-03 | 2006-10-31 | Innovative Pharmaceutical Concepts (Ipc) Inc. | Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
| AR043161A1 (es) * | 2003-02-14 | 2005-07-20 | Sucampo Pharmaceuticals Inc | Composicion oftalmica para tratar hipertension ocular y glaucoma |
| TWI495471B (zh) * | 2003-08-12 | 2015-08-11 | R Tech Ueno Ltd | 促進毛髮生長之組成物及方法 |
| CA3099517C (en) * | 2012-07-13 | 2022-04-26 | Santen Pharmaceutical Co., Ltd. | Combinations comprising a sulfonamide compound for the treatment of glaucoma or ocular hypertension |
| US9980946B1 (en) | 2017-01-25 | 2018-05-29 | Effcon Laboratories, Inc. | Extended release methazolamide formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3785602T2 (de) * | 1986-03-13 | 1993-09-02 | Univ Columbia | Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom. |
| EP0286903B2 (en) * | 1987-04-03 | 2000-03-29 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
| JPH0739343B2 (ja) * | 1988-10-01 | 1995-05-01 | 株式会社アールテック・ウエノ | 眼圧降下剤 |
| ATE108330T1 (de) * | 1987-09-18 | 1994-07-15 | R Tech Ueno Ltd | Hypotensive okulare mittel. |
| EP0366279B1 (en) * | 1988-10-01 | 1994-09-21 | R-Tech Ueno Ltd. | Ocular hypotensive agents |
-
1992
- 1992-02-10 TW TW081100863A patent/TW210287B/zh not_active IP Right Cessation
- 1992-02-20 DE DE69210286T patent/DE69210286T2/de not_active Expired - Lifetime
- 1992-02-20 ES ES92301412T patent/ES2089387T3/es not_active Expired - Lifetime
- 1992-02-20 AT AT92301412T patent/ATE137407T1/de not_active IP Right Cessation
- 1992-02-20 EP EP92301412A patent/EP0501678B1/en not_active Expired - Lifetime
- 1992-02-20 DK DK92301412.0T patent/DK0501678T3/da active
- 1992-02-26 CA CA002061907A patent/CA2061907C/en not_active Expired - Lifetime
- 1992-02-28 JP JP4043018A patent/JP2511611B2/ja not_active Expired - Lifetime
- 1992-02-29 KR KR1019920003307A patent/KR100221369B1/ko not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/487,637 patent/US5547968A/en not_active Expired - Lifetime
-
1996
- 1996-05-02 GR GR960401080T patent/GR3019820T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100221369B1 (ko) | 1999-09-15 |
| GR3019820T3 (en) | 1996-08-31 |
| JP2511611B2 (ja) | 1996-07-03 |
| KR920017654A (ko) | 1992-10-21 |
| CA2061907C (en) | 2003-04-08 |
| US5547968A (en) | 1996-08-20 |
| CA2061907A1 (en) | 1992-09-02 |
| TW210287B (enExample) | 1993-08-01 |
| DE69210286T2 (de) | 1996-09-12 |
| EP0501678A3 (en) | 1992-12-16 |
| EP0501678A2 (en) | 1992-09-02 |
| ES2089387T3 (es) | 1996-10-01 |
| ATE137407T1 (de) | 1996-05-15 |
| DE69210286D1 (de) | 1996-06-05 |
| JPH0565227A (ja) | 1993-03-19 |
| EP0501678B1 (en) | 1996-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
| MX9204381A (es) | Metodo para tratar inflamacion ocular | |
| ATE175875T1 (de) | Tirilazad parentale formulierung mit einem co- lösungsmittel | |
| FI932254A7 (fi) | Menetelmä dipalmitoyylifosfaridyylikoliinidispersioiden antamiseksi | |
| ATE193647T1 (de) | Di- und trivalente kleine moleküle als selektininhibitoren | |
| PT97785A (pt) | Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina | |
| DE69010162D1 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
| DK0651999T3 (da) | Fremgangsmåder til inhibering af livmoderfibrose | |
| DK0458588T3 (da) | Behandling af okulær hypertension med en synergistisk kombination til okulær administration | |
| EA200100716A1 (ru) | Способ профилактики рака молочной железы | |
| KR950702120A (ko) | 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis) | |
| EP0501678A3 (en) | Treatment of ocular hypertension with a synergistic combination | |
| DK0662325T3 (da) | Inhibering af ovariedysgenese, forsinket pubertet eller sexuel infantilisme | |
| DK0458589T3 (da) | Behandling af okulær hypertension med en okulær synergistisk kombination | |
| DK0458590T3 (da) | Behandling af okulær hypertension med en synergistisk konbination | |
| DK0458587T3 (da) | Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse | |
| ATE134992T1 (de) | Salze von n-nitrosophenylhydroxylamin | |
| DE69301387D1 (de) | Behandlung des Glaukoms mit synergistischer Kombination | |
| ATE82850T1 (de) | Verwendung von 2-pyrimidinyl-1-piperazinderivaten. | |
| DK0740657T3 (da) | 4-Arylisoindoler med analgetisk virkning | |
| DK0458537T3 (da) | Anvendelse af en terapeutisk forbindelse til behandling af bronkitis | |
| DK0791355T3 (da) | Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi | |
| DK435089A (da) | Anvendelse af zofenopril til behandling af rheumatoid arthritis | |
| DK0900085T3 (da) | Behandling af overdreven aggression med olanzapin | |
| ATE232724T1 (de) | Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes |